Company & Sponsor Intelligence
National Center for Complementary and Integrative Health (NCCIH)
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed3
Countries1
Therapeutic footprint
depressionepilepsyparkinsons
Indexed studies
NCT00029276Magnetic Stimulation for Parkinson Disease
parkinsons · United StatesPHASE1
parkinsons · United StatesPHASE1
NCT00067301PUFA Augmentation in Treatment of Major Depression
depression · United StatesPHASE3
depression · United StatesPHASE3
NCT00871377Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures
epilepsy · United StatesPHASE2
epilepsy · United StatesPHASE2
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →